Doxorubicin-Induced Hypersensitivity Reactions
- 1 October 1984
- journal article
- case report
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 18 (10) , 808-811
- https://doi.org/10.1177/106002808401801007
Abstract
An uncommon side effect of the anthracycline antibiotics is allergic reactions. We report three patients treated with doxorubicin hydrochloride who developed systemic hypersensitivity reactions to the drug. In all three cases, the onset of the reaction coincided with the initiation of the doxorubicin, and was confirmed by rechallenge with the drug. An urticarial rash with pruritis was the primary clinical manifestation seen in all cases. All reactions responded to treatment with diphenhydramine, or diphenhydramine and hydrocortisone. None of the reactions were life-threatening or required hospitalization of the patient. In two patients, use of the drug was discontinued because of the reaction. Pretreatment with diphenhydramine, prednisone, and cimetidine may have reduced the severity of the reaction in one patient.Keywords
This publication has 14 references indexed in Scilit:
- A controlled trial of therapy in chronic urticariaJournal of Allergy and Clinical Immunology, 1981
- Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double-blind studyBritish Journal of Dermatology, 1981
- CIMETIDINE IN CHRONIC URTICARIAThe Lancet, 1980
- The effect of H and H blockade on cutaneous histamine response in manJournal of Allergy and Clinical Immunology, 1980
- Angioneurotic Edema from DoxorubicinNew England Journal of Medicine, 1979
- RESPONSES OF HUMAN SKIN BLOOD VESSELS TO SYNTHETIC HISTAMINE ANALOGUESBritish Journal of Clinical Pharmacology, 1978
- RECEPTORS FOR HISTAMINE IN HUMAN SKIN BLOOD VESSELS: A REVIEWBritish Journal of Dermatology, 1977
- Vascular reactions to histamine and compound 48/80 in human skin: suppression by a histamine H2-receptor blocking agent.Published by Wiley ,1977
- Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignanciesCancer, 1976
- Management of Adult Acute Myelogenous LeukaemiaBMJ, 1973